Smith & Nephew plc (LON:SN)

Market Cap	10.82B +21.0%
Revenue (ttm)	4.33B +5.4%
Net Income	358.03M +61.0%
EPS	0.41 +59.9%
Shares Out	849.81M
PE Ratio	31.28
Forward PE	15.78
Dividend	0.28 (2.21%)
Ex-Dividend Date	Oct 2, 2025

Volume	4,062,710
Average Volume	3,090,546
Open	1,266.00
Previous Close	1,267.00
Day's Range	1,264.00 - 1,276.50
52-Week Range	937.80 - 1,441.50
Beta	0.65
RSI	57.20
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 17,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD